| LTRN 0001763950 | |||
|---|---|---|---|
| Filing Date | Form Type | Description | Document |
| 2024-05-09 | 10-Q | View Document | |
| 2024-05-09 | 8-K | View Document | |
| 2024-05-03 | ARS | View Document | |
| 2024-04-29 | DEF 14A | View Document | |
| 2024-04-26 | 144 | View Document | |
| 2024-04-26 | 144 | View Document | |
| 2024-04-26 | 144 | View Document | |
| 2024-04-26 | 144 | View Document | |
| 2024-04-26 | 144 | View Document | |
| 2024-03-18 | 10-K | View Document | |
| 2024-03-18 | 8-K | View Document | |
| 2024-03-01 | SC 13D/A | SC 13D/A | View Document |
| 2024-02-29 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2024-02-29 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2024-02-28 | 144 | View Document | |
| 2024-02-28 | 144 | View Document | |
| 2024-02-28 | 144 | View Document | |
| 2024-02-14 | SC 13G/A | View Document | |
| 2024-01-19 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2024-01-19 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2023-12-29 | 8-K | View Document | |
| 2023-12-01 | SC 13D/A | SC 13D/A | View Document |
| 2023-12-01 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2023-12-01 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2023-11-24 | 8-K | View Document | |
| 2023-11-08 | 10-Q | View Document | |
| 2023-11-08 | 8-K | View Document | |
| 2023-10-20 | 8-K | View Document | |
| 2023-08-09 | 10-Q | View Document | |
| 2023-08-09 | 8-K | View Document | |
| 2023-06-21 | 8-K | View Document | |
| 2023-05-09 | 8-K | View Document | |
| 2023-05-09 | 10-Q | View Document | |
| 2023-05-05 | ARS | View Document | |
| 2023-04-28 | DEF 14A | View Document | |
| 2023-03-20 | 10-K | View Document | |
| 2023-03-20 | 8-K | View Document | |
| 2023-01-18 | 8-K | View Document | |
| 2022-11-21 | SC 13G | View Document | |
| 2022-11-09 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2022-11-09 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2022-11-07 | 10-Q | View Document | |
| 2022-11-07 | 8-K | View Document | |
| 2022-10-24 | 4 | View Document | |
| 2022-09-07 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2022-09-07 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2022-08-09 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2022-08-08 | 10-Q | View Document | |
| 2022-08-08 | 8-K | View Document | |
| 2022-06-17 | 3 | View Document | |
| 2022-06-14 | 8-K | CURRENT REPORT | View Document |
| 2022-05-03 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | View Document |
| 2022-05-03 | 10-Q | QUARTERLY REPORT | View Document |
| 2022-05-03 | 8-K | CURRENT REPORT | View Document |
| 2022-04-27 | DEF 14A | DEFINITIVE PROXY STATEMENT | View Document |
| 2022-04-26 | 8-K | CURRENT REPORT | View Document |
| 2022-04-25 | 8-K | CURRENT REPORT | View Document |
| 2022-03-22 | SC 13D/A | SC 13D/A | View Document |
| 2022-03-22 | 8-K | CURRENT REPORT | View Document |
| 2022-03-21 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-03-10 | 10-K | ANNUAL REPORT | View Document |
| 2022-03-10 | 8-K | CURRENT REPORT | View Document |
| 2022-01-24 | 8-K | CURRENT REPORT | View Document |
| 2022-01-11 | SC 13G/A | LANTERN PHARMA INC. | View Document |
| 2021-11-22 | 8-K | CURRENT REPORT | View Document |
| 2021-11-08 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-11-08 | 4 | View Document | |
| 2021-11-08 | 4 | View Document | |
| 2021-11-08 | 4 | View Document | |
| 2021-11-08 | 4 | View Document | |
| 2021-11-02 | 4 | View Document | |
| 2021-11-02 | 4 | View Document | |
| 2021-11-01 | 10-Q | QUARTERLY REPORT | View Document |
| 2021-11-01 | 8-K | CURRENT REPORT | View Document |
| 2021-07-29 | 10-Q | QUARTERLY REPORT | View Document |
| 2021-07-29 | 8-K | CURRENT REPORT | View Document |
| 2021-07-12 | EFFECT | View Document | |
| 2021-07-08 | CORRESP | View Document | |
| 2021-07-07 | UPLOAD | View Document | |
| 2021-07-02 | S-3 | REGISTRATION STATEMENT | View Document |
| 2021-05-25 | 8-K | CURRENT REPORT | View Document |
| 2021-05-03 | 8-K | CURRENT REPORT | View Document |
| 2021-05-03 | 10-Q | QUARTERLY REPORT | View Document |
| 2021-04-09 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | View Document |
| 2021-04-09 | DEF 14A | DEFINITIVE PROXY STATEMENT | View Document |
| 2021-03-10 | 10-K | ANNUAL REPORT | View Document |
| 2021-03-10 | 8-K | CURRENT REPORT | View Document |
| 2021-02-16 | SC 13G | SC 13G | View Document |
| 2021-02-16 | SC 13G | SC 13G | View Document |
| 2021-01-25 | SC 13G | LANTERN PHARMA INC. | View Document |
| 2021-01-19 | 4 | FORM 4 SUBMISSION | View Document |
| 2021-01-15 | 424B4 | PROSPECTUS SUPPLEMENT | View Document |
| 2021-01-15 | S-1MEF | REGISTRATION STATEMENT | View Document |
| 2021-01-14 | EFFECT | View Document | |
| 2021-01-11 | CORRESP | View Document | |
| 2021-01-11 | FWP | FREE WRITING PROSPECTUSES | View Document |
| 2021-01-08 | CORRESP | View Document | |
| 2021-01-08 | S-1 | REGISTRATION STATEMENT | View Document |
| 2021-01-06 | 8-K | CURRENT REPORT | View Document |
| 2020-12-21 | UPLOAD | View Document | |
